company background image
A043

Seouleaguer KOSDAQ:A043710 Stock Report

Last Price

₩1.52k

Market Cap

₩59.5b

7D

2.0%

1Y

-1.9%

Updated

16 May, 2022

Data

Company Financials
A043710 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

A043710 Stock Overview

Seouleaguer Co., Ltd., a medical beauty care platform company, provides hospital management support services in South Korea.

Seouleaguer Competitors

 

 

 

 

 

 

 

 

 

 

 

 

Price History & Performance

Summary of all time highs, changes and price drops for Seouleaguer
Historical stock prices
Current Share Price₩1,520.00
52 Week High₩2,045.00
52 Week Low₩894.00
Beta1
1 Month Change3.05%
3 Month Change55.26%
1 Year Change-1.93%
3 Year Change-39.68%
5 Year Change-63.42%
Change since IPO-94.57%

Recent News & Updates

Apr 09
Is Seouleaguer (KOSDAQ:043710) A Risky Investment?

Is Seouleaguer (KOSDAQ:043710) A Risky Investment?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

Dec 25
Here's Why Seouleaguer (KOSDAQ:043710) Can Afford Some Debt

Here's Why Seouleaguer (KOSDAQ:043710) Can Afford Some Debt

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Shareholder Returns

A043710KR HealthcareKR Market
7D2.0%-2.5%0.006%
1Y-1.9%-44.5%-15.8%

Return vs Industry: A043710 exceeded the KR Healthcare industry which returned -43.5% over the past year.

Return vs Market: A043710 exceeded the KR Market which returned -15.2% over the past year.

Price Volatility

Is A043710's price volatile compared to industry and market?
A043710 volatility
A043710 Average Weekly Movement17.3%
Healthcare Industry Average Movement5.9%
Market Average Movement5.5%
10% most volatile stocks in KR Market10.3%
10% least volatile stocks in KR Market3.2%

Stable Share Price: A043710 is more volatile than 90% of KR stocks over the past 3 months, typically moving +/- 17% a week.

Volatility Over Time: A043710's weekly volatility has increased from 11% to 17% over the past year.

About the Company

FoundedEmployeesCEOWebsite
199111Paek-Chol Kimhttps://www.seouleaguer.net

Seouleaguer Co., Ltd., a medical beauty care platform company, provides hospital management support services in South Korea. The company was formerly known as Rocketmobile Co., Ltd. and changed its name to Seouleaguer Co., Ltd.

Seouleaguer Fundamentals Summary

How do Seouleaguer's earnings and revenue compare to its market cap?
A043710 fundamental statistics
Market Cap₩59.53b
Earnings (TTM)-₩1.21b
Revenue (TTM)₩14.87b

4.0x

P/S Ratio

-49.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
A043710 income statement (TTM)
Revenue₩14.87b
Cost of Revenue₩14.83b
Gross Profit₩47.46m
Other Expenses₩1.25b
Earnings-₩1.21b

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-30.79
Gross Margin0.32%
Net Profit Margin-8.11%
Debt/Equity Ratio8.6%

How did A043710 perform over the long term?

See historical performance and comparison

Valuation

Is Seouleaguer undervalued compared to its fair value and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • PE vs Industry

  • PE vs Market

  • PEG Ratio

  • PB vs Industry


>50%

Undervalued compared to fair value

Share Price vs. Fair Value

Below Fair Value: A043710 (₩1520) is trading below our estimate of fair value (₩36303.93)

Significantly Below Fair Value: A043710 is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: A043710 is unprofitable, so we can't compare its PE Ratio to the Asian Healthcare industry average.

PE vs Market: A043710 is unprofitable, so we can't compare its PE Ratio to the KR market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate A043710's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: A043710 is overvalued based on its PB Ratio (2.3x) compared to the KR Healthcare industry average (2.2x).


Future Growth

How is Seouleaguer forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

Future Growth Score

0/6

Future Growth Score 0/6

  • Earnings vs Savings Rate

  • Earnings vs Market

  • High Growth Earnings

  • Revenue vs Market

  • High Growth Revenue

  • Future ROE


17.0%

Forecasted Healthcare industry annual growth in earnings

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Seouleaguer has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Seouleaguer performed over the past 5 years?

Past Performance Score

0/6

Past Performance Score 0/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


-50.0%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: A043710 is currently unprofitable.

Growing Profit Margin: A043710 is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: A043710 is unprofitable, and losses have increased over the past 5 years at a rate of 50% per year.

Accelerating Growth: Unable to compare A043710's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A043710 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (34.8%).


Return on Equity

High ROE: A043710 has a negative Return on Equity (-10.95%), as it is currently unprofitable.


Financial Health

How is Seouleaguer's financial position?

Financial Health Score

5/6

Financial Health Score 5/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: A043710's short term assets (₩20.5B) exceed its short term liabilities (₩8.0B).

Long Term Liabilities: A043710's short term assets (₩20.5B) exceed its long term liabilities (₩4.6B).


Debt to Equity History and Analysis

Debt Level: A043710 has more cash than its total debt.

Reducing Debt: Insufficient data to determine if A043710's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable A043710 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: A043710 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 7.1% per year.


Dividend

What is Seouleaguer current dividend yield, its reliability and sustainability?

Dividend Score

0/6

Dividend Score 0/6

  • Notable Dividend

  • High Dividend

  • Stable Dividend

  • Growing Dividend

  • Earnings Coverage

  • Future Dividend Coverage

Dividend Yield vs Market

Notable Dividend: Unable to evaluate A043710's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate A043710's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if A043710's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if A043710's dividend payments have been increasing.


Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as A043710 has not reported any payouts.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?


CEO

Paek-Chol Kim (56 yo)

no data

Tenure

Paek-Chol Kim serves as Chief Executive Officer of Playtech Co., Ltd. Paek-Chol Kim was employed by Allianz Life Insurance Co., Ltd. Paek-Chol Kim completed Graduate School of Hanyang University.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.4%.


Top Shareholders

Company Information

Seouleaguer Co., Ltd.'s employee growth, exchange listings and data sources


Key Information

  • Name: Seouleaguer Co., Ltd.
  • Ticker: A043710
  • Exchange: KOSDAQ
  • Founded: 1991
  • Industry: Health Care Services
  • Sector: Healthcare
  • Implied Market Cap: ₩59.530b
  • Shares outstanding: 39.16m
  • Website: https://www.seouleaguer.net

Number of Employees


Location

  • Seouleaguer Co., Ltd.
  • 10, Nonhyeon-ro 163-gil
  • 4th Floor
  • Seoul
  • South Korea

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/05/16 00:00
End of Day Share Price2022/05/16 00:00
Earnings2021/12/31
Annual Earnings2021/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.